[Editor’s Note: Meddevicetracker recently published a report covering the prostate cancer diagnosis and minimally invasive treatments spaces, and the report’s author, Phil Greenfield, spoke to Medtech Insight in a special audio interview. (Also see "Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment" - Medtech Insight, 12 May, 2022.)]
Paige, a spin-out from the Memorial Sloan Kettering cancer center in New York, has obtained its seventh CE mark – this time for its Paige Prostate Biomarker Suite (PPBS). PPBS...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?